CCC
JNJ icon

Crescent Capital Consulting’s Johnson & Johnson JNJ Stock Holding History

Crescent Capital Consulting’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$3.17M Sell
18,539
-613
-3% -$100K 0.52% 44
2021
Q3 		$3.09M Sell
19,152
-1,000
-5% -$171K 0.57% 44
2021
Q2 		$3.32M Sell
20,152
-596
-3% -$98.7K 0.62% 44
2021
Q1 		$3.41M Buy
20,748
+1,296
+7% +$210K 0.75% 40
2020
Q4 		$3.06M Buy
+19,452
New +$2.87M 0.79% 31

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Crescent Capital Consulting's JNJ Position: Q4 2021 in Review

Crescent Capital Consulting reduced its Johnson & Johnson (JNJ) stake by 3.2% in Q4 2021, selling an estimated $100K and leaving 18,539 shares worth $3.17M. The position accounts for 0.52% of the portfolio, ranked #44.

Crescent Capital Consulting first reported a position in JNJ in Q4 2020 and has held it in 5 quarters since. The position peaked at $3.41M in Q1 2021. 3,644 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.

  • Crescent Capital Consulting held 18,539 shares of Johnson & Johnson worth $3.17M as of Q4 2021.
  • Crescent Capital Consulting sold 613 Johnson & Johnson shares in Q4 2021, an estimated $100K.
  • Johnson & Johnson made up 0.52% of Crescent Capital Consulting's portfolio in Q4 2021, its #44 holding.
  • Crescent Capital Consulting first reported a position in Johnson & Johnson in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's Johnson & Johnson position peaked at $3.41M in Q1 2021.
  • 3,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.